Ebstein's anomaly of the tricuspid valve prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Changing Category:DiseaseState to Category:Disease)
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
__NOTOC__
__NOTOC__
'''Associate Editor-In-Chief:''' {{CZ}}
'''Associate Editor-In-Chief:''' {{CZ}}
==Prognosis==


===Adverse prognostic factors are===
===Adverse prognostic factors are===
Line 15: Line 17:


e)Paradoxical emboli
e)Paradoxical emboli


==References==
==References==
Line 22: Line 25:


{{Congenital malformations and deformations of circulatory system}}
{{Congenital malformations and deformations of circulatory system}}
[[Category:DiseaseState]]
[[Category:Cardiology]]
[[Category:Pediatrics]]
{{WH}}  
{{WH}}  


{{WS}}
{{WS}}
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Pediatrics]]

Latest revision as of 17:57, 12 December 2011

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebstein's anomaly of the tricuspid valve prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebstein's anomaly of the tricuspid valve prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebstein's anomaly of the tricuspid valve prognosis

CDC on Ebstein's anomaly of the tricuspid valve prognosis

Ebstein's anomaly of the tricuspid valve prognosis in the news

Blogs on Ebstein's anomaly of the tricuspid valve prognosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebstein's anomaly of the tricuspid valve prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]

Prognosis

Adverse prognostic factors are

a) NYHA Class III or IV

b) Moderate to severe cardiomegaly

c) Cyanosis or an O2 sat < 90%

d) Disability during infancy

e)Paradoxical emboli


References


Template:WH

Template:WS